Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer.

De Laere B, Oeyen S, Mayrhofer M, Whitington T, van Dam PJ, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert EG, De Maeseneer D, Strijbos M, Bols A, Fransis K, Beije N, de Kruijff IE, van Dam V, Brouwer A, Goossens D, Heyrman L, Van den Eynden GG, Rutten A, Del Favero J, Rantalainen M, Rajan P, Sleijfer S, Ullén A, Yachnin J, Grönberg H, Van Laere SJ, Lindberg J, Dirix LY.

Clin Cancer Res. 2018 Sep 12. pii: clincanres.1943.2018. doi: 10.1158/1078-0432.CCR-18-1943. [Epub ahead of print]

PMID:
30209161
2.

Correction to: Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit.

Guidet B, Flaatten H, Boumendil A, Morandi A, Andersen FH, Artigas A, Bertolini G, Cecconi M, Christensen S, Faraldi L, Fjølner J, Jung C, Marsh B, Moreno R, Oeyen S, Öhman CA, Pinto BB, Soliman IW, Szczeklik W, Valentin A, Watson X, Zafeiridis T, De Lange DW; VIP1 Study Group.

Intensive Care Med. 2018 Sep;44(9):1598-1601. doi: 10.1007/s00134-018-5312-8.

PMID:
30128586
3.

Predicting outcomes in very old ICU patients: time to focus on the past?

Flaatten H, Oeyen S, deLange DW.

Intensive Care Med. 2018 Aug;44(8):1344-1345. doi: 10.1007/s00134-018-5262-1. Epub 2018 Jul 2. No abstract available.

PMID:
29968014
4.

Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit.

Guidet B, Flaatten H, Boumendil A, Morandi A, Andersen FH, Artigas A, Bertolini G, Cecconi M, Christensen S, Faraldi L, Fjølner J, Jung C, Marsh B, Moreno R, Oeyen S, Öhman CA, Pinto BB, Soliman IW, Szczeklik W, Valentin A, Watson X, Zafeiridis T, De Lange DW; VIP1 study group.

Intensive Care Med. 2018 Jul;44(7):1027-1038. doi: 10.1007/s00134-018-5196-7. Epub 2018 May 17. Erratum in: Intensive Care Med. 2018 Sep;44(9):1598-1601.

PMID:
29774388
5.

Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.

De Laere B, Oeyen S, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, Van Kerckhove P, De Maeseneer D, Strijbos M, Bols A, Fransis K, Beije N, de Kruijff I, van Dam V, Brouwer A, van Dam PJ, Van den Eynden G, Rutten A, Sleijfer S, Vandebroek J, Van Laere S, Dirix L.

Prostate. 2018 May;78(6):435-445. doi: 10.1002/pros.23488. Epub 2018 Feb 12.

PMID:
29431193
6.

The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years).

Flaatten H, De Lange DW, Morandi A, Andersen FH, Artigas A, Bertolini G, Boumendil A, Cecconi M, Christensen S, Faraldi L, Fjølner J, Jung C, Marsh B, Moreno R, Oeyen S, Öhman CA, Pinto BB, Soliman IW, Szczeklik W, Valentin A, Watson X, Zaferidis T, Guidet B; VIP1 study group.

Intensive Care Med. 2017 Dec;43(12):1820-1828. doi: 10.1007/s00134-017-4940-8. Epub 2017 Sep 21.

PMID:
28936626
7.

Development of a prediction model for long-term quality of life in critically ill patients.

Oeyen S, Vermeulen K, Benoit D, Annemans L, Decruyenaere J.

J Crit Care. 2018 Feb;43:133-138. doi: 10.1016/j.jcrc.2017.09.006. Epub 2017 Sep 6.

PMID:
28892669
8.

Critically ill octogenarians and nonagenarians: evaluation of long-term outcomes, posthospital trajectories and quality of life one year and seven years after ICU discharge.

Oeyen S, Vermassen J, Piers R, Benoit D, Annemans L, Decruyenaere J.

Minerva Anestesiol. 2017 Jun;83(6):598-609. doi: 10.23736/S0375-9393.16.11434-8. Epub 2016 Nov 30.

9.
10.

Long-term quality of life in critically ill patients with acute kidney injury treated with renal replacement therapy: a matched cohort study.

Oeyen S, De Corte W, Benoit D, Annemans L, Dhondt A, Vanholder R, Decruyenaere J, Hoste E.

Crit Care. 2015 Aug 6;19:289. doi: 10.1186/s13054-015-1004-8.

11.

Influence of smart real-time electronic alerting on glucose control in critically ill patients.

Colpaert K, Oeyen S, Sijnave B, Peleman R, Benoit D, Decruyenaere J.

J Crit Care. 2015 Feb;30(1):216.e1-6. doi: 10.1016/j.jcrc.2014.07.030. Epub 2014 Aug 7.

PMID:
25194590
12.

Low serum creatine kinase activity is associated with worse outcome in critically ill patients.

Van de Moortel L, Speeckaert MM, Fiers T, Oeyen S, Decruyenaere J, Delanghe J.

J Crit Care. 2014 Oct;29(5):786-90. doi: 10.1016/j.jcrc.2014.03.010. Epub 2014 Mar 21.

PMID:
24703388
13.

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.

Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, Jauregui L, Krell K, Pachl J, Takahashi T, Peckelsen C, Cordasco E, Chang CS, Oeyen S, Aikawa N, Maruyama T, Schein R, Kalil AC, Van Nuffelen M, Lynn M, Rossignol DP, Gogate J, Roberts MB, Wheeler JL, Vincent JL; ACCESS Study Group.

JAMA. 2013 Mar 20;309(11):1154-62. doi: 10.1001/jama.2013.2194.

PMID:
23512062
14.

Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study.

Oeyen SG, Benoit DD, Annemans L, Depuydt PO, Van Belle SJ, Troisi RI, Noens LA, Pattyn P, Decruyenaere JM.

Intensive Care Med. 2013 May;39(5):889-98. doi: 10.1007/s00134-012-2791-x. Epub 2012 Dec 18.

PMID:
23248039
15.

Quality of life after intensive care: a systematic review of the literature.

Oeyen SG, Vandijck DM, Benoit DD, Annemans L, Decruyenaere JM.

Crit Care Med. 2010 Dec;38(12):2386-400. doi: 10.1097/CCM.0b013e3181f3dec5. Review.

PMID:
20838335
16.

A 50-year-old man with severe hypercalcemia: a case report.

Van den Hauwe K, Oeyen SG, Schrijvers BF, Decruyenaere JM, Buylaert WA.

Acta Clin Belg. 2009 Sep-Oct;64(5):442-6.

PMID:
19999395
17.

Comment on "Health-related quality of life as a prognostic factor of survival in critically ill patients".

Vandijck DM, Oeyen SG, Annemans L, Decruyenaere JM.

Intensive Care Med. 2009 Jul;35(7):1308; author reply 1309. doi: 10.1007/s00134-009-1476-6. Epub 2009 Apr 3. No abstract available.

PMID:
19343321
18.

Do you (still) believe in tight blood glucose control?

Oeyen S.

Crit Care Med. 2008 Dec;36(12):3277-8. doi: 10.1097/CCM.0b013e31818f26c1. No abstract available.

PMID:
19020444
19.

Hyperglycaemia upon onset of ICU-acquired bloodstream infection is associated with adverse outcome in a mixed ICU population.

Vandijck DM, Oeyen SG, Buyle EM, Claus BO, Blot SI, Decruyenaere JM.

Anaesth Intensive Care. 2008 Jan;36(1):25-9.

20.

Acute kidney injury, length of stay, and costs in patients hospitalized in the intensive care unit.

Vandijck DM, Oeyen S, Decruyenaere JM, Annemans L, Hoste EA.

Acta Clin Belg. 2007;62 Suppl 2:341-5.

PMID:
18283996
21.

Long-term outcome after acute kidney injury in critically-ill patients.

Oeyen S, Vandijck D, Benoit D, Decruyenaere J, Annemans L, Hoste E.

Acta Clin Belg. 2007;62 Suppl 2:337-40. Review.

PMID:
18283995
22.

Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection.

Vandijck DM, Depaemelaere M, Labeau SO, Depuydt PO, Annemans L, Buyle FM, Oeyen S, Colpaert KE, Peleman RP, Blot SI, Decruyenaere JM.

Int J Antimicrob Agents. 2008 Feb;31(2):161-5. doi: 10.1016/j.ijantimicag.2007.10.015.

PMID:
18164599
23.

Adherence to and efficacy and safety of an insulin protocol in the critically ill: a prospective observational study.

Oeyen SG, Hoste EA, Roosens CD, Decruyenaere JM, Blot SI.

Am J Crit Care. 2007 Nov;16(6):599-608.

24.

Closing the gap between knowledge and behavior: Mission impossible?

Oeyen S.

Crit Care Med. 2007 Sep;35(9):2219-20. No abstract available.

PMID:
17713374
25.

Fresh frozen plasma transfusion in the critically ill: yes, no, or maybe?

Oeyen S.

Crit Care Med. 2007 Jul;35(7):1777-8. No abstract available.

PMID:
17581362
26.

About protocols and guidelines: it's time to work in harmony!

Oeyen S.

Crit Care Med. 2007 Jan;35(1):292-3. Review. No abstract available.

PMID:
17197768
27.

Admission hyperglycemia and outcome: the ongoing story.

Oeyen S.

Crit Care Med. 2005 Dec;33(12):2848-9. No abstract available.

PMID:
16352972

Supplemental Content

Support Center